Sangami Pugazenthi Awarded 2023 ABTA Lucien Rubinstein Award for ‘Radiation Resistance in Grade 2 Meningiomas’
Sangami Pugazenthi is rewarded for her research exploring biological processes behind radiation resistance in grade 2 meningiomas.
What is your brain tumor story? Click here to share it and join the community!
Sign up for our bi-monthly email to get the latest news on treatments, support, and stories from the brain tumor community.
Sangami Pugazenthi is rewarded for her research exploring biological processes behind radiation resistance in grade 2 meningiomas.
**Sponsored Content**
There’s no stopping Janice Armbrust. Discover how her passion for hiking is helping her thrive with glioblastoma.
**Sponsored Content**
Discover how Mayo Clinic is leveraging minimally invasive surgical techniques to maximize tumor resection while making recovery easier for patients.
Discover how a brain tumor diagnosis led Bri to live a more fulfilling life and how she’s helping others do the same.
A new year brings new opportunities to make a difference in the brain tumor community and empower yourself!
**Sponsored Content**
Learn more about Biodexa’s Phase 1 clinical trial investigating the effectiveness of an approved blood cancer drug in liquid form to treat recurrent glioblastoma (GBM).
For National Family Caregivers Month, Robin Ferrill shares tips from her experience embracing the role after her husband’s GBM diagnosis in 2022.
From groundbreaking research to new collaborations at a federal level, discover the top three brain tumor news highlights and milestones for the year.
After losing her husband to GBM in 2022 and receiving her own diagnosis, survivor Beth Kassab didn’t know what to expect attending the largest brain tumor conference in Chicago. Read Beth’s top takeaways: